Elana Clar

Dr. Clar is one of the most highly trained neurologists in the country for the treatment of movement disorders. After completing her residency at Georgetown University, she completed a two-year movement disorders fellowship at Mount Sinai Beth Israel Medical Center, where she received specialized training in Deep Brain Stimulation (DBS).

She specializes in the evaluation and treatment of Parkinson’s disease, essential tremor, dystonia, and other complex movement disorders, with particular expertise in advanced therapies including Deep Brain Stimulation and MRI-guided Focused Ultrasound. Dr. Clar works closely with neurosurgical colleagues to evaluate patients who may benefit from surgical treatment options when medications are no longer providing adequate symptom control.

Dr. Clar is dedicated to improving care for patients, and spreading awareness about Parkinson’s and other movement disorders. She is a firm believer in integrative medicine and the complementary role exercise, nutrition and alternative therapies play in helping patients maximize their quality of life. Dr. Clar has participated in groundbreaking research for the treatment of Parkinson’s disease, including serving as a sub-investigator for the Parkinson’s Progression Marker Initiative, a landmark observational study that helped identify biomarkers for the progression of Parkinson’s disease. She often speaks to both professional and patient communities to promote education about Parkinson’s disease and other movement disorders, and to advocate for patients, families and caregivers.

Dr. Clar views her relationship with patients as a partnership, and she is dedicated to serving as an advocate for them. From working with insurance companies to ensure her patients’ medications are covered, to researching and monitoring the newest treatment options available, she ensures each patient receives the best care possible.

Dr. Clar has been widely recognized in national media, including on CBS Mornings Health Watch, for her efforts to support patients with Parkinson’s disease.